Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 48% ± 21% | |
lung | 17 studies | 29% ± 10% | |
peripheral blood | 15 studies | 26% ± 10% | |
eye | 10 studies | 43% ± 18% | |
kidney | 6 studies | 24% ± 4% | |
intestine | 6 studies | 25% ± 10% | |
heart | 5 studies | 29% ± 7% | |
liver | 5 studies | 34% ± 17% | |
bone marrow | 4 studies | 25% ± 6% | |
adipose | 4 studies | 28% ± 8% | |
pancreas | 3 studies | 43% ± 21% | |
lymph node | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3690.18 | 1445 / 1445 | 100% | 28.19 | 183 / 183 |
prostate | 100% | 4130.29 | 245 / 245 | 100% | 13.83 | 501 / 502 |
uterus | 100% | 5936.94 | 170 / 170 | 100% | 15.61 | 458 / 459 |
ovary | 100% | 5079.91 | 180 / 180 | 100% | 14.99 | 429 / 430 |
lung | 100% | 4982.72 | 578 / 578 | 100% | 15.88 | 1151 / 1155 |
breast | 100% | 5373.76 | 459 / 459 | 99% | 21.04 | 1112 / 1118 |
thymus | 100% | 4255.02 | 653 / 653 | 99% | 14.28 | 600 / 605 |
brain | 99% | 2902.51 | 2625 / 2642 | 100% | 10.69 | 702 / 705 |
bladder | 100% | 4569.52 | 21 / 21 | 98% | 11.82 | 492 / 504 |
pancreas | 99% | 2658.74 | 326 / 328 | 98% | 10.92 | 174 / 178 |
stomach | 100% | 3084.46 | 359 / 359 | 97% | 15.52 | 277 / 286 |
adrenal gland | 100% | 2251.46 | 258 / 258 | 96% | 11.29 | 220 / 230 |
intestine | 100% | 4304.60 | 966 / 966 | 96% | 11.39 | 504 / 527 |
kidney | 100% | 2226.83 | 89 / 89 | 92% | 11.71 | 831 / 901 |
skin | 100% | 4174.28 | 1809 / 1809 | 89% | 11.03 | 418 / 472 |
liver | 94% | 1121.67 | 212 / 226 | 66% | 4.67 | 268 / 406 |
blood vessel | 100% | 4591.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.18 | 29 / 29 |
muscle | 100% | 2984.64 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4110.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.68 | 1 / 1 |
adipose | 100% | 4530.07 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 2247.52 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 3153.91 | 783 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 64% | 5.69 | 51 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0022604 | Biological process | regulation of cell morphogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0008360 | Biological process | regulation of cell shape |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0043568 | Biological process | positive regulation of insulin-like growth factor receptor signaling pathway |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0005158 | Molecular function | insulin receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PHIP |
Protein name | PH-interacting protein (PHIP) (DDB1- and CUL4-associated factor 14) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11) Pleckstrin homology domain interacting protein |
Synonyms | DCAF14 WDR11 |
Description | FUNCTION: Probable regulator of the insulin and insulin-like growth factor signaling pathways. Stimulates cell proliferation through regulation of cyclin transcription and has an anti-apoptotic activity through AKT1 phosphorylation and activation. Plays a role in the regulation of cell morphology and cytoskeletal organization. . |
Accessions | ENST00000700114.1 ENST00000275034.5 ENST00000700013.1 A0A8V8TQM4 ENST00000700115.1 A0A8V8TPV5 A0A8V8TPK0 ENST00000700119.1 A0A8V8TP75 ENST00000700012.1 ENST00000700171.1 A0A8V8TQP5 A0A8V8TQZ3 ENST00000700118.1 Q8WWQ0 A0A8V8TPB8 |